Thomas Casdagli
Director/Board Member en MVM Scotland (No. 3) GP Ltd. .
Fortuna: 82 023 $ al 31/03/2024
Perfil
Thomas Theodore Casdagli is currently a Director at Xention Pharma Ltd., eZono AG, MVM Executive Ltd., MVM (CIP) (No.3) Ltd., MVM (CIP) (No.2) Ltd., MVM (GP) Ltd., MVM (GP) (No.
2) Ltd., and Dassiet Oy.
He is also a Partner at MVM Partners LLP.
In the past, he served as Chairman at Patient Connect Ltd., Non-Executive Director at Lombard Medical Technologies Ltd., Alliance Pharma Plc, Avantium International BV, and Heptares Therapeutics Ltd.
He was also a Member-Supervisory Board at Valneva SE from 2019 to 2021.
He received his undergraduate degree from the University of Oxford in 1998.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ALLIANCE PHARMA PLC
0.03% | 01/03/2024 | 163 552 ( 0.03% ) | 82 023 $ | 31/03/2024 |
Cargos activos de Thomas Casdagli
| Empresas | Cargo | Inicio |
|---|---|---|
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Private Equity Investor | 01/01/2002 |
| MVM Executive Ltd. | Director/Board Member | 27/10/2010 |
| MVM (CIP) (No.2) Ltd. | Director/Board Member | 27/10/2010 |
| MVM (CIP) (No.3) Ltd. | Director/Board Member | 27/10/2010 |
| MVM (GP) Ltd. | Director/Board Member | 27/10/2010 |
| MVM (GP) (No. 2) Ltd. | Director/Board Member | 27/10/2010 |
| MVM Scotland (No. 3) GP Ltd. | Director/Board Member | 27/10/2010 |
| MVM Gp (No.3) Scottish LP | Director/Board Member | - |
Dassiet Oy
 Dassiet Oy Medical SpecialtiesHealth Technology Onbone Oy develops medical casting and splinting materials for use in the fields of orthopaedics, traumatology and occupational therapy. The company was founded by Petro Antero Kirmo Lahtinen, Antti Pärssinen, Jari Juhani Salo, Matti Eino Olavi Vaheri, and Karri Airola on November 18, 2008 and is headquartered in Oulu, Finland. | Director/Board Member | 01/11/2014 |
| ░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Antiguos cargos conocidos de Thomas Casdagli.
| Empresas | Cargo | Fin |
|---|---|---|
| ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formación de Thomas Casdagli.
| University of Oxford | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ALLIANCE PHARMA PLC | Health Technology |
| VALNEVA | Health Technology |
| Empresas privadas | 15 |
|---|---|
Lombard Medical Technologies Ltd.
 Lombard Medical Technologies Ltd. Medical SpecialtiesHealth Technology Lombard Medical Technologies Ltd. was a medical technology company, which specialized in research and development, design, manufacture and commercialization of endovascular solutions. The company was founded in July 2000 and wass headquartered in London, the United Kingdom. | Health Technology |
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Health Technology |
| Avantium International BV | Industrial Services |
MVM Partners LLP
MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Finance |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Health Technology |
eZono AG
 eZono AG Medical SpecialtiesHealth Technology eZono AG develops portable ultrasound system. Its product eZono 3000 is a portable ultrasound system designed for the needs of anaesthetists. The company was founded by Allan R. Dunbar and Andre Jaekel in July 2004 and is headquartered in Jena, Germany. | Health Technology |
| MVM Executive Ltd. | |
| MVM (CIP) (No.3) Ltd. | |
| MVM (CIP) (No.2) Ltd. | |
| MVM (GP) Ltd. | |
| MVM (GP) (No. 2) Ltd. | |
Dassiet Oy
Dassiet Oy Medical SpecialtiesHealth Technology Onbone Oy develops medical casting and splinting materials for use in the fields of orthopaedics, traumatology and occupational therapy. The company was founded by Petro Antero Kirmo Lahtinen, Antti Pärssinen, Jari Juhani Salo, Matti Eino Olavi Vaheri, and Karri Airola on November 18, 2008 and is headquartered in Oulu, Finland. | Health Technology |
| MVM Gp (No.3) Scottish LP | |
| MVM Scotland (No. 3) GP Ltd. | |
Patient Connect Ltd.
 Patient Connect Ltd. Medical/Nursing ServicesHealth Services Patient Connect Ltd. provides supporting services for patients at the point of dispensing. It operates a community where pharmacists provide medicines to help patients. The firm offers patient compliance services. The company was founded by Grace Lomax and Zoe Barker in 2004 and is headquartered in Guildford, the United Kingdom. | Health Services |
- Bolsa de valores
- Insiders
- Thomas Casdagli
